Does Aspirin Decrease the Risk of Preterm Birth in Preeclampsia?
This study by van Vliet et al. (Obstetrics Gynecology, 2017) sought to determine if antiplatelet agents reduce the risk of spontaneous preterm birth.
Systematic Review and Meta-Analysis
17 studies, including 28,797 women, which randomized women to receive low-dose aspirin/dipyridamole vs. placebo/no treatment to prevent preeclampsia were reviewed. Women in the antiplatelet treatment group had lower risk of spontaneous preterm birth at < 37 weeks and <34 weeks than women in the placebo and no treatment groups. The difference was more marked in women who had a previous pregnancy. The authors conclude that antiplatelet treatment is effective in decreasing the risk of spontaneous preterm birth in the setting of preeclampsia.
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan